Compact detector unlocks reactor's neutrino mystery with first-ever detection
The results were achieved using the CONUS+ experiment and provide an observation of Coherent Elastic Neutrino-Nucleus Scattering (CEvNS) from a reactor source at full coherence.
'The CEvNS measurement provides unique insights into fundamental physical processes within the Standard Model of particle physics, the current theory describing the structure of our universe,' said the researchers in a press release.
Neutrinos do not scatter off
The experiment is situated 20.7 meters from the core of the Leibstadt nuclear power plant in Switzerland. It uses three 1 kg (2.2 lbs) germanium semiconductor detectors to identify CEvNS, a process where a low-energy neutrino interacts with an entire atomic nucleus.
'In this process, neutrinos do not scatter off the individual components of the atomic nuclei in the detector, but rather coherently with the entire nucleus. This significantly increases the probability of a very small but observable nuclear recoil,' explained the press release.
The process can be compared to a ping-pong ball hitting a car; the recoil of the car, though small, is the observable effect. In this case, antineutrinos from the reactor scattered off germanium nuclei in the detectors.
Over a measurement period of 119 days between 2023 and 2024, the team recorded an excess of 395±106 neutrino signals after subtracting background and interfering signals. The position of the detector receives a flux of more than 1013 (ten trillion) neutrinos per square centimeter per second from the reactor.
"This value is in very good agreement with theoretical calculations, within the measurement uncertainty," remarked the press release.
"We have thus successfully confirmed the sensitivity of the CONUS+ experiment and its ability to detect antineutrino scattering from atomic nuclei," added Dr. Christian Buck, an author of the study.
Neutrino detection requires large experiments
Neutrinos are elementary particles that interact weakly with matter, and their detection has typically required very large experiments. The CEvNS effect was theorized in 1974 and first observed by the COHERENT experiment at a particle accelerator in 2017. The CONUS+ result is the first observation of the effect from a reactor at these low energies.
The CEvNS technique may have future applications. Dr. Buck noted the potential to develop small, mobile neutrino detectors to monitor reactor heat output or isotope concentration.
The measurement also provides data for testing the Standard Model of particle physics. According to the authors, the CONUS+ measurements have a reduced dependence on nuclear physics aspects compared to other experiments, improving the sensitivity to physics beyond the Standard Model.
"The techniques and methods used in CONUS+ have excellent potential for fundamental new discoveries," concluded Professor Manfred Lindner, the project's initiator.
"The groundbreaking CONUS+ results could therefore mark the starting point for a new field in neutrino research."
The experiment was equipped with improved and larger detectors in autumn 2024, with the aim of increasing measurement accuracy.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
2 hours ago
- Medscape
These Markers May Predict Risk for Bone Loss in SLE
TOPLINE: Osteoporosis was prevalent in 41% of patients with systemic lupus erythematosus (SLE). Factors such as lupus nephritis classes III and IV, U1-ribonucleoprotein (RNP) antibodies, and longer disease duration were associated with lower areal bone mineral density (BMD), and active lupus nephritis was associated with osteoporosis. METHODOLOGY: Researchers analysed data of a subcohort of patients from a prospective observational study to identify factors associated with BMD and the risk for osteoporosis. They included 110 patients with SLE (mean age, 48 years; 92% women) from a hospital in Berlin between July 2015 and January 2022 who fulfilled the American College of Rheumatology/ European League Against Rheumatism 2019 SLE classification criteria and had current or prior glucocorticoid treatment. The analysis included SLE disease activity and a standardised bone health assessment with the DEXA scan and trabecular bone score measurement according to national guidelines. BMD- and osteoporosis-related factors were assessed. The following three co-primary endpoints were assessed: Areal BMD, expressed as the lowest DEXA-derived T score at the lumbar spine (L1-L4), total hip, or femoral neck A composite osteoporosis outcome (a femoral or lumbar spine T score ≤ -2.5 and/or history of a major fragility fracture and/or antiosteoporotic treatment) The prevalence of fragility fractures (any, vertebral, and non-vertebral). TAKEAWAY: Overall, 41% and 35% of patients with SLE had osteoporosis and lupus nephritis, respectively. Factors significantly associated with lower areal BMD included lupus nephritis classes III and IV (P = .025), U1-RNP antibodies (P = .009), higher C-reactive protein levels (P = .015), and longer disease duration (P = .001). Clinical remission (P = .033) and higher Health Assessment Questionnaire scores (P = .009) were positively correlated with areal BMD. Active lupus nephritis was strongly associated with osteoporosis in patients with SLE (odds ratio [OR], 7.42; P = .027), along with other factors such as older age (OR, 1.06; P = .003) and lower Health Assessment Questionnaire scores (OR, 0.29; P = .005). IN PRACTICE: "The identification of SLE-specific risk factors allows us to recognize patients at particular high risk for OP [osteoporosis]. This prompts us to suggest a thorough osteoporosis check-up in patients with high CRP [C-reactive protein], LN [lupus nephritis], or U1-RNP-antibodies," the authors wrote. SOURCE: This study was led by Edgar Wiebe, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, Berlin, Germany. It was published online on July 28, 2025, in Arthritis Research & Therapy. LIMITATIONS: This monocentric cohort study primarily involved White Caucasians, thereby limiting the generalisability of the findings to other patient groups. A potential selection bias may have resulted in overrepresentation of patients with more severe disease courses who were at a high risk for osteoporosis. The cross-sectional design limited the ability to establish causality between identified factors and outcomes. DISCLOSURES: Open access funding was enabled and organised by Projekt DEAL. The prospective observational study received a joint funding from AbbVie, Amgen, Alfasigma, Almirall, Biogen, BMS, Chugai, Fresenius Kabi, Galapagos, GA Generic Assays, GSK, Hexal, Horizon Therapeutics, Lilly, Medac, Mundipharma, Novartis, Pfizer, Roche, Sanofi-Genzyme, and UCB. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Medscape
2 hours ago
- Medscape
New KPIs May Cut Post-Endoscopy GI Cancer Risk
TOPLINE: A consensus on major and minor key performance indicators (KPIs) was established to improve the quality of upper gastrointestinal (GI) endoscopy and reduce post-endoscopy upper GI cancer. The adoption of the proposed recommendations could minimise the threefold variation in post-endoscopy cancer rates among providers in England. METHODOLOGY: Researchers identified potential KPIs from the systematic review (up to December 2021), National Cancer Registry and Hospital Episode Statistics Database Analysis, and National Endoscopy Database Analysis. The cancer registry analysis included the data of 98,801 patients diagnosed with upper GI cancer within 3 years of a cancer-negative endoscopy in England between 2009 and 2018. Researchers used the modified nominal group technique through two online workshops moderated by James Lind Alliance facilitators. Overall, this study included 14 clinicians, three nurse endoscopists, two upper GI cancer nurse specialists, 14 patients and their relatives and representatives, and four observers. KPIs were categorised as endoscopy provider or endoscopist/procedure related. The ranking of KPIs was based on their relative importance in reducing post-endoscopy upper GI cancer, where the top 10 with lower scores were designated as major indicators and the remaining ones minor. TAKEAWAY: Four major provider-related KPIs were identified, of which the monitoring of post-endoscopy upper GI cancer rates with minimum standards of 7% or less and maintaining less intense endoscopy lists with less than 10 points per list were ranked the highest. A total of six major endoscopist-related KPIs were specified, of which adequate examination time of at least 7 minutes and dedicated training in the recognition of early upper GI neoplasia were ranked the highest. Five KPIs were ranked as minor, which included the detection rate for premalignant conditions, use of image enhancement techniques, photo documentation of anatomical sites for minimum standards of more than 90% of diagnostic upper GI endoscopies, neoplasia detection rate, and use of artificial intelligence. IN PRACTICE: "This consensus provides a list of major and minor KPIs to improve the quality of endoscopy and reduce PEUGIC [post-endoscopy upper GI cancer]," the authors wrote, suggesting that, "this framework will enable endoscopy providers to monitor their performance and ensure the provision of a high-quality UGI endoscopy service for their patients." SOURCE: This study was led by Umair Kamran, Sandwell and West Birmingham NHS Trust, Birmingham, England. It was published online on July 24, 2025, in United European Gastroenterology Journal. LIMITATIONS: Most of the evidence examined was graded as low-to-moderate quality due to the lack of well-designed trials. The applicability of the recommendations may be limited outside the UK because the consensus included only UK participants. Additional limitations included insufficient evidence to suggest minimum standards for some measures and bias in consensus statements due to weak evidence. DISCLOSURES: This study received funding from the National Institute for Health and Care Research under its Research for Patient Benefit Programme. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
3 hours ago
- Yahoo
Plastic causing "disease and death from infancy to old age," report warns
Plastic pollution is a "grave, growing and under-recognized danger" to health that is costing the world at least $1.5 trillion a year, a report published Monday in the Lancet medical journal said. The new review of existing evidence, which was carried out by leading health researchers and doctors, was published one day ahead of fresh talks in Geneva aiming at getting the world's first treaty on plastic pollution. The experts called for the delegates from nearly 180 nations expected to attend the gathering to finally agree on a treaty after previous failed attempts. Comparing plastic to air and lead pollution, the report said the impact on health of plastic pollution could be mitigated by laws and policies. "Plastics cause disease and death from infancy to old age and are responsible for health-related economic losses exceeding $1.5 trillion annually," it said. A recent umbrella review of epidemiological research on the health impacts of plastic chemicals showed "consistent evidence for multiple health effects at all stages of human life for many plastic chemicals" and found that infants and young children were especially at risk, the report said. "These effects include impaired reproductive potential (eg, polycystic ovary syndrome and endometriosis), perinatal effects (eg, miscarriage, reduced birthweight, and malformations of the genital organs), diminished cognitive function (eg, intelligence quotient loss), insulin resistance, hypertension and obesity in children, and type 2 diabetes, cardiovascular disease, stroke, obesity, and cancer in adults." "It is incumbent on us to act in response," Philip Landrigan, a doctor and researcher at Boston College, said in a statement responding to the report. "To those meeting in Geneva: please take up the challenge and the opportunity of finding the common ground that will enable meaningful and effective international cooperation in response to this global crisis." The researchers also warned about tiny pieces of plastic called microplastics that have been found throughout nature - and throughout human bodies. The full effect of microplastics on health are not yet fully known, but researchers have sounded the alarm about the potential impact of this ubiquitous plastic. The amount of plastic produced by the world has risen from two million tons in 1950 to 475 million tons in 2022, the report said. The number is projected to triple by 2060, yet currently less than 10 percent of all plastic is recycled, it added. Plastic is made from fossil fuels, and Landrigan said that the world's plastic "crisis" is connected to its climate crisis. "There is no understating the magnitude of both the climate crisis and the plastic crisis," Landrigan said. "They are both causing disease, death and disability today in tens of thousands of people, and these harms will become more severe in the years ahead as the planet continues to warm and plastic production continues to increase," he said. Black swimmers teach others amid history of aquatic segregation How safe is our Social Security safety net? In Gaza, hunger forces impossible choices as Hamas releases propaganda video of hostage
